ULURU INC. ANNOUNCES ALTRAZEAL® AGREEMENT FOR THE EUROPEAN MARKET

10/13/2011

Addison, Texas, October 13, 2011; ULURU Inc. (NYSE AMEX: ULU), announced today that it has signed a binding letter of intent with Melmed Holdings AG, a company based in Switzerland, to license Altrazeal® for the European Union. Read More